The U.S. Food and Drug Administration (FDA) has approved a new antipsychotic for schizophrenia. Cobenfy (xanomeline and trospium chloride) capsules…
Read More
The U.S. Food and Drug Administration (FDA) has approved a new antipsychotic for schizophrenia. Cobenfy (xanomeline and trospium chloride) capsules…
Read More